We examined the role of Astragaloside IV (AS-IV) on impaired wound healing in streptozotocin-induced diabetic mice.
Administration of AS-IV accelerates diabetic wound healing.
AS-IV promotes collagen deposition and ECM synthesis.
AS-IV improved the new blood vessel formation in wound tissue.
The effect of AS-IV is associated with upregulation of alternatively activated macrophages (AAM).